ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,427.13
-2.31%
US Tech 100
18,601.20
-3.24%
Dow Jones
39,853.87
-1.25%
Brent Oil
80.425
-0.38%
Bitcoin
64,276.39
-1.68%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Fulcrum Therapeutics Inc (FULC)

  7. Fulcrum Therapeutics Inc (FULC) News

FULC

Fulcrum Therapeutics (FULC)

Fulcrum Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FULC
DateTimeSourceHeadlineSymbolCompany
07/08/20248:00AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
06/18/20244:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
06/18/20244:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
06/18/20244:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
06/17/20244:37PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FULCFulcrum Therapeutics Inc
05/13/20247:15AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FULCFulcrum Therapeutics Inc
05/13/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FULCFulcrum Therapeutics Inc
05/09/20244:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
03/08/20246:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
03/08/20246:00PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
03/05/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
02/27/20245:18PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:FULCFulcrum Therapeutics Inc
02/27/20245:12PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:FULCFulcrum Therapeutics Inc
02/27/20244:01PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:FULCFulcrum Therapeutics Inc
02/27/20247:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FULCFulcrum Therapeutics Inc
01/30/20249:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
01/30/20249:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
11/07/20237:05AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FULCFulcrum Therapeutics Inc
11/07/20237:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FULCFulcrum Therapeutics Inc
10/02/20234:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FULCFulcrum Therapeutics Inc
08/22/20237:48AMDow Jones NewsFulcrum Therapeutics Shares Rally Premarket as FDA Lifts Study HoldNASDAQ:FULCFulcrum Therapeutics Inc
08/22/20237:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FULCFulcrum Therapeutics Inc
08/11/20234:53PMGlobeNewswire Inc.Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:FULCFulcrum Therapeutics Inc
08/03/20237:11AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FULCFulcrum Therapeutics Inc
08/03/20237:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FULCFulcrum Therapeutics Inc
07/10/20235:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FULCFulcrum Therapeutics Inc
07/07/20235:30PMGlobeNewswire Inc.Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:FULCFulcrum Therapeutics Inc
07/03/20234:16PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FULCFulcrum Therapeutics Inc
06/29/20234:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FULCFulcrum Therapeutics Inc
06/29/20234:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FULCFulcrum Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:FULC

Your Recent History

NASDAQ
NVDA
NVIDIA
USOTC
RXMD
Progressive Care (QB)
USOTC
KEGS
1812 Brewing (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
ITUP
Interups (CE)
USOTC
RSPI
RespireRx Pharmaceuticals (CE)
USOTC
HIRU
Hiru (PK)
AMEX
SPY
SPDR S&P 500
NASDAQ
TSLA
Tesla
USOTC
ENZC
Enzolytics (PK)
USOTC
RDGL
Vivos (QB)
NASDAQ
NB
NioCorp Developments
NYSE
AMC
AMC Entertainment
USOTC
RONN
Ronn Motor (PK)
USOTC
BLEG
Branded Legacy (PK)
USOTC
IFUS
Impact Fusion (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved